GlassScriptPhysician profile
William R Salter
NPI 1811999600
$48,036.35
in general payments reported to CMS, 2019-2025
46 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,735 · 2020: $1,912 · 2021: $774 · 2022: $663 · 2023: $8,049 · 2024: $8,529 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $3,573 · Consulting Fee: $2,625 · Food and Beverage: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,600.00 |
| Travel and Lodging | $3,573.45 |
| Consulting Fee | $2,625.00 |
| Food and Beverage | $2,153.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $31,887.18 | 2022-2025 | Zynrelef, Aponvie |
| Pacira Pharmaceuticals Incorporated | $8,090.56 | 2019-2025 | Exparel |
| Channel Medsystems, INC. | $2,766.29 | 2021-2025 | |
| Aegea Medical, INC. | $1,455.00 | 2020 | |
| Abbvie INC. | $745.61 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $393.78 | 2019-2025 | Paragard T 380a |
| Organon LLC | $300.54 | 2021-2025 | Nexplanon, Jada System |
| Millicent US INC | $205.86 | 2020-2025 | Intrarosa, Femlyv |
| Pfizer INC. | $186.57 | 2021-2024 | |
| Therapeuticsmd, INC. | $178.93 | 2019-2021 | |
| Exeltis, USA INC. | $168.74 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $154.69 | 2022-2025 | Veozah |
| Coloplast Corp | $104.10 | 2019 | |
| Integra Lifesciences Corporation | $101.16 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baxter Healthcare | $85.50 | 2019-2024 | Perclot |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.